telehealth glp-1 weight loss provider us Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight TeleHealthNP Weight Loss & Anti-Aging

3-4 days from application to treatment start Consultation Format Asynchronous review of intake form by licensed provider

In December 2014, the Food and Drug Administration (FDA) approved liraglutide for weight loss, and semaglutide was approved for diabetes in 2017 and obesity in 2021, opening a new era of obesity treatment

Most weight loss research has focused on naltrexone combined with bupropion (a different antidepressant), which is FDA-approved as Contrave

10.3109/00498254.2015.1129080 Xenobiotica 154 ZouD.LouJ.KeJ.MeiS.LiJ.GongY.et al (2018)

It has additional benefits for conditions like chronic depression and pancreatitis